Vidipha Central Pharmaceutical JSC

VND 33,000As of Sun 8 Nov 2026, 12:00 UTC
HOSE:VDPHealthcare
Country Vietnam
PE (Fwd) •••
TSR 9Y CAGR 8.95%
Div yield 7.58%
ROE —
Pharmaceutical Preparations
Beta (5Y) (0.07)
PE TTM 11.02
TSR TTM (8.39%)
Mkt cap VND 728.8B
ROIC 11.38%
SE Grade™
Value
Quality
Moat
Consensus
Reference
VND 39,757
20.48%
(43.37%)
Hold 2|11|11|5|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareVND
409.50
404.44
419.18
446.45
2.12%
(8.43%)
(5.14%)
3.79%
RevenueVND B
44.74
46.75
46.85
49.23
15.61%
14.84%
15.51%
16.23%
Peers (US$28.38M)
Cap (US$)
PE
56.18M
15.60x
28.77M
18.26x
Capital
TTM
5Y
10Y
Leveragex
0.231
(0.084)
(0.072)
EBIT/Intx
0.928
0.066
0.065
Own earn%
(17.40)
51.69
51.49
Sh yield%
27.27
37.45
45.75
Owners
Insiders/Inst%
9.48
78.96
Short interest%
2.48
SBC / revenue%
2.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
25–36
$1 testx
—
Incr. ROIC%
68